These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 24006906)

  • 21. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
    Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis.
    Wu Y; Huang J; Zhong G; Lan J; Lin H; Zhang Q
    Reprod Biomed Online; 2022 Feb; 44(2):380-388. PubMed ID: 34895827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility].
    Zhou LM; Zheng J; Sun YT; Zhao YY; Xia AL
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):334-7. PubMed ID: 24016474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.
    Lai TH; Lee FK; Lin TK; Horng SG; Chen SC; Chen YH; Wang PC
    Fertil Steril; 2009 Aug; 92(2):508-14. PubMed ID: 18701101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of clinical outcomes of four protocols for frozen-thawed embryo transfer cycle].
    Chen SL; He JX; Song HD; Li SZ; Liu XN; Li H; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):303-6. PubMed ID: 17425978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: An RCT.
    Eslami Moayed M; Moini A; Kashani L; Farid Mojtahedi M; Rezaee T; Tabasizadeh H; Maajani K; Yamini N
    Int J Reprod Biomed; 2023 Jun; 21(6):481-490. PubMed ID: 37560066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endometrial preparation for frozen-thawed euploid blastocyst transfer: a prospective randomized trial comparing clinical results from natural modified cycle and exogenous hormone stimulation with GnRH agonist.
    Greco E; Litwicka K; Arrivi C; Varricchio MT; Caragia A; Greco A; Minasi MG; Fiorentino F
    J Assist Reprod Genet; 2016 Jul; 33(7):873-84. PubMed ID: 27221477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone levels do not differ between patients with or without endometriosis/adenomyosis both in those who conceive after hormone replacement therapy-frozen embryo transfer cycles and those who do not.
    Bourdon M; Sorel M; Maignien C; Guibourdenche J; Patrat C; Marcellin L; Jobin T; Chapron C; Santulli P
    Hum Reprod; 2024 Jun; ():. PubMed ID: 38850031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer.
    Wang Y; Yi YC; Guu HF; Chen YF; Kung HF; Chang JC; Chen LY; Chuan ST; Chen MJ
    Sci Rep; 2023 Apr; 13(1):6741. PubMed ID: 37185812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
    Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
    Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation.
    van der Houwen LE; Mijatovic V; Leemhuis E; Schats R; Heymans MW; Lambalk CB; Hompes PG
    Reprod Biomed Online; 2014 Jan; 28(1):39-46. PubMed ID: 24262434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of the endometrial preparation protocols for frozen-thawed embryo transfer cycles in women with endometriosis.
    Yang J; Wen Y; Li D; Hou X; Peng B; Wang Z
    Reprod Biol Endocrinol; 2023 Sep; 21(1):83. PubMed ID: 37670354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
    Hsieh YY; Chang CC; Tsai HD
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the outcome of frozen-thawed embryo transfer.
    Veleva Z; Orava M; Nuojua-Huttunen S; Tapanainen JS; Martikainen H
    Hum Reprod; 2013 Sep; 28(9):2425-31. PubMed ID: 23756705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First case successful twin pregnancy by transdermal therapy for patients with 5.0 mm thick endometrium during frozen-thawed embryo transfer: a case report.
    Zhao H; Huang B; Xiao N; Li Y
    Gynecol Endocrinol; 2015; 31(12):922-4. PubMed ID: 26652195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.
    Lahoud R; Kwik M; Ryan J; Al-Jefout M; Foley J; Illingworth P
    Arch Gynecol Obstet; 2012 Feb; 285(2):535-40. PubMed ID: 21853250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.